TITLE

Iatrogenic Osteomalacia and Myopathy due to Phosphate Depletion

AUTHOR(S)
Baker, L. R. I.; Ackrill, P.; Cattell, W. R.; Stamp, T. C. B.; Watson, L.
PUB. DATE
July 1974
SOURCE
British Medical Journal;7/20/1974, Vol. 3 Issue 5924, p150
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111116

 

Related Articles

  • Osteomalacic dialysis osteodystrophy: a trial of phospate-enriched dialysis fluid. Feest, T.G.; Ward, M.K.; Ellis, H.A.; Aljama, P.; Kerr, D.N.S. // British Medical Journal;1/7/1978, Vol. 1 Issue 6104, p18 

    To assess whether phosphate depletion is an aetiological factor in osteomalacic dialysis osteodystrophy we undertook a prospective trial of phosphate-enriched dialysis fluid, in association with oral 1-hydroxycholecalciferol, for this condition. Thirty patients started the trial; of the 27...

  • Oncogenic hypophosphatemic osteomalacia. Agus, Zalman S. // Kidney International;Jul1983, Vol. 24 Issue 1, p113 

    Presents a discussion concerning a case of oncogenic hypophosphatemic osteomalacia. Clinical manifestations; Vitamin D-resistant rickets due to tumor-induced or so-called oncogenic osteomalacia; Interrelationship between renal phosphate transport and vitamin D metabolism; Differential diagnosis...

  • Osteomalacia in adolescents presenting as proximal myopathy. AL-Otaibi, Hessah M.; M AL-Jurayyan, Nasir A.; Mohamed, Sarar; Salih, Mustafa A. M. // Current Pediatric Research;Jan-Jun2012, Vol. 16 Issue 1, p57 

    We report three adolescent patients with osteomalacia who presented initially with clinical features consistent with proximal myopathy. All patients had low serum level of 25 hydroxy vitamin D. Furthermore, radiological investigations confirmed osteomalacia. Myopathy responded well to...

  • OSTEOMALACIA INDUCIDA POR TUMOR: HEMANGIOPERICITOMA RINOSINUSAL. SERAFINI, ENRIQUETA M.; PISAREVSKY, ANA A.; GARRIDO, JAVIER PLUMET; ZAMORA, RAFAEL J.; PETRUCCI, ENRIQUE A. // Medicina (Buenos Aires);2013, Vol. 73 Issue 1, p39 

    Tumor-induced osteomalacia: rhinosinusal hemangiopericytoma. Tumor-induced osteomalacia is a rare disease of bone metabolism. The characteristic of this disease is an increase in phosphate excretion followed by hypophosphatemia, due to phosphaturic agents produced by different types of tumors....

  • An interesting case of reversible metabolic myopathy: Tumor induced osteomalacia. Reddy, Hanmayyagari Babul; Mounika, Guntaka; Nagesh, V. Sri; Rao, I. Satish // Annals of Indian Academy of Neurology;Apr2014, Vol. 17 Issue 2, p237 

    A letter to the editor is presented regarding the inclusion of tumor induced osteomalacia (TIO) in the diagnosis of painful myopathy.

  • Hyperphosphataemic rickets: a new variant.  // British Medical Journal (Clinical Research Edition);12/10/1983, Vol. 287 Issue 6407, p1765 

    Examines the abnormalities characteristic of rickets and osteomalacia in Kenya. Increase of plasma phosphate concentrations; Influence of genetic factors in the pathogenesis of osteomalacia; Occurrence of hyperphosphatemia with florid rickets.

  • ALUMINIUM - A CHEMICAL NEUROTOXIC AGENT. TAUS, N.; FARRAJ, M.; TĂNASE, S.; MIRONESCU, A.; BOICU, M.; NECULA, V.; TAUS, L. // Bulletin of the Transilvania University of Brasov, Seriels VI: M;2013, Vol. 6 Issue 2, p1 

    This work is a synthesis of expert studies that describe-induced toxicity aluminum in humans and animals, using different routes of administration. Due to its toxicity, aluminium, is the impugned in the pathogenesis of certain diseases, including Alzheimer's disease, encephalopathy, patients...

  • Rickets--vitamin D deficiency and dependency. Sahay, Manisha; Sahay, Rakesh // Indian Journal of Endocrinology & Metabolism;Mar2012, Vol. 16 Issue 2, p164 

    Rickets is an important problem even in countries with adequate sun exposure. The causes of rickets/osteomalacia are varied and include nutritional deficiency, especially poor dietary intake of vitamin D and calcium. Non-nutritional causes include hypophosphatemic rickets primarily due to renal...

  • Hypophosphataemic osteomalacia in patients receiving haemodialysis. Mahony, J.F.; Hayes, J.M.; Ingham, J.P.; Posen, S. // British Medical Journal;7/17/1976, Vol. 2 Issue 6028, p142 

    Examines the effect of hemodialysis in patients with hypophosphatemic osteomalacia. Increase in serum inorganic phosphate concentrations; Assessment on the levels of serum phosphate and alkaline phosphatase; Effectiveness in phosphate-binding agents in reducing serum inorganic phosphates.

  • 1-34 PTH Could Reverse Impaired Bone Mineralization Induced By the Overdose of Bisphosphonate. Kyeong Hye Park; Kwang Joon Kim; Han Seok Choi; Kyoung Min Kim; Eun Young Lee; Seonhui Han; Hyun Sil Kim; Daham Kim; Hannah Seok; Eun Yeong Choe; Yumie Rhee; Sung-Kil Lim // Endocrinology & Metabolism;Sep2012, Vol. 27 Issue 3, p247 

    Bisphosphonates are the mainstay of osteoporosis treatment. Despite the fact that bisphosphonates have a relatively good safety record and are tolerated well by the majority of patients, serious adverse events have been associated with their use. A 41-year-old man had been diagnosed with...

Share

Read the Article

Other Topics